| 英文名称 | 中文名称 | CAS | MF |
|
Deuterated Crosslinker DSP-d8
|
Deuterated Crosslinker DSP-d8
|
1639836-65-9
|
C14H8D8N2O8S2
|
|
DI-FMOC-SELENO-L-CYSTINE
|
DI-FMOC-SELENO-L-CYSTINE
|
1639843-33-6
|
C36H32N2O8Se2
|
|
(2E)-3-(2,5-dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
|
(2E)-3-(2,5-dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
|
1639856-62-4
|
C18H18O4
|
|
3-Amino-5-ethynylbenzoic acid
|
3-AMINO-5-ETHYNYLBENZOIC ACID
|
1639866-72-0
|
C9H7NO2
|
|
(2R,5R)-2,5-DiMethylMorpholine hydrochloride
|
2R,5R-二甲基吗啉盐酸盐
|
1639886-52-4
|
C6H14ClNO
|
|
tBID
|
1639895-85-4
|
1639895-85-4
|
C11H3Br4N3O2
|
|
(2S,5R)-2,5-diMethylMorpholine
|
2S,5R-二甲基吗啉
|
1639924-58-5
|
C6H13NO
|
|
(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid
|
原研518-12
|
1639970-62-9
|
C22H23NO4
|
|
TH588 (hydrochloride)
|
1640282-30-9
|
1640282-30-9
|
C13H13Cl3N4
|
|
I-CBP112
|
化合物I-CBP112
|
1640282-31-0
|
C27H36N2O5
|
|
Oclacitinib maleate
|
PF-03394197
|
1640292-55-2
|
C19H27N5O6S
|
|
(2R)-2-AMINO-2-(6-METHOXY(3-PYRIDYL))ETHAN-1-OL DIHYDROCHLORIDE
|
1640848-71-0
|
1640848-71-0
|
C8H13ClN2O2
|
|
(S)-2-Amino-2-(2-methoxypyridin-4-yl)ethanol dihydrochloride
|
1640848-91-4
|
1640848-91-4
|
C8H14Cl2N2O2
|
|
(R)-2-Amino-2-(2-methoxypyridin-4-yl)ethanol dihydrochloride
|
1640848-93-6
|
1640848-93-6
|
C8H14Cl2N2O2
|
|
17878-A2
|
1640894-12-7
|
1640894-12-7
|
C26H22N2O5
|
|
17878-A3
|
1640894-15-0
|
1640894-15-0
|
C26H24N2O5
|
|
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldodec-11-enoic acid
|
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldodec-11-enoic acid
|
1640968-91-7
|
C28H35NO4
|
|
Tofacitinib Impurity 77
|
托法替尼杂质
|
1640971-51-2
|
C16H20N6O2
|
|
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
|
托法替尼杂质
|
1640971-60-3
|
C14H20N6O
|
|
Tofacitinib Impurity 6
|
托法替尼杂质 6
|
1640972-35-5
|
C16H22N6O
|
|
1H,3H-Furo[3,4-c]isoxazole, 6a-(5-bromo-2-fluorophenyl)tetrahydro-1-[(1R)-1-phenylpropyl]-, (3aS,6aS)-
|
|
1640975-25-2
|
C20H21BrFNO2
|
|
2,6-bis[4-(diphenylamino)phenyl]- 9,10-Anthracenedione
|
2,6-双[4-二苯胺基苯基]-9,10-蒽醌
|
1640978-33-1
|
C50H34N2O2
|
|
2-(4-Bromo-2-formylphenoxy)acetic acid
|
((6-氯吡啶-2-基)甲基)氨基甲酸叔丁酯
|
1640995-60-3
|
C11H15ClN2O2
|
|
2-Ethoxy-5-(ethoxyMethyl)thiazole
|
2-甲氧基-5-(乙氧基甲基)噻唑
|
1640995-61-4
|
C8H13NO2S
|
|
(2-Aminothiazol-5-yl)methanol hydrochloride
|
(2-氨基噻唑-5-基)甲醇盐酸盐
|
1640995-62-5
|
C4H7ClN2OS
|
|
(4-Chloropyridin-2-yl)methanamine hydrochloride
|
2-氨甲基-4-氯吡啶
|
1640995-63-6
|
C6H8Cl2N2
|
|
tert-butyl4-((2S,5S)-1-((4-nitrophenyl)sulfonyl)-5-(((4-nitrophenyl)sulfonyl)oxy)piperidine-2-carboxamido)piperidine-1-carboxylate
|
|
1640998-70-4
|
C28H35N5O12S2
|
|
Methyl 4-cyano-2-(trifluoromethyl)benzoate
|
4-氰基-2-(三氟甲基)苯甲酸甲酯
|
1641588-74-0
|
C10H6F3NO2
|
|
Alfacalcidol-D6
|
阿尔法骨化醇-D6
|
1641940-94-4
|
C27H44O2
|
|
Mavacamten
|
玛伐凯泰
|
1642288-47-8
|
C15H19N3O2
|
|
SRN-927)
|
1642297-01-5
|
1642297-01-5
|
C28H28FNO4
|
|
3-(fluoromethyl)azetidine hydrochloride
|
3-(氟甲基)氮杂环丁烷盐酸盐
|
1642298-59-6
|
C4H9ClFN
|
|
KPT-8602
|
CS-2388
|
1642300-52-4
|
C17H10F6N6O
|
|
KPT-8602 (Z-isomer)
|
1642300-78-4
|
1642300-78-4
|
C17H10F6N6O
|
|
PDE1-IN-1 (phosphate)
|
1642303-38-5
|
1642303-38-5
|
C29H29FN7O5P
|
|
22-(tert-Butoxy)-22-oxodocosanoic acid
|
22-(叔丁氧基)-22-氧代二十烷酸
|
1642333-05-8
|
C26H50O4
|
|
4,7-dibromo-5,6-bis((2-ethylhexyl)oxy)benzo[c][1,2,5]thiadiazole
|
PM241
|
1642535-94-1
|
C22H34Br2N2O2S
|
|
Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers)
|
氯唑西林EP杂质B
|
1642559-64-5
|
C18H20ClN3O4S
|
|
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
1642571-07-0
|
C22H22N6O
|
|
Glumetinib
|
谷美替尼
|
1642581-63-2
|
C21H17N9O2S
|
|
1-Isopropyl-4-(4,4,5,5-tetraMethyl-[1,3,2]dioxaborolan-2-yl)-1,2,3,6-tetrahydro-pyridine
|
1-异丙基-4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)-1,2,3,6-四氢吡啶
|
1642583-50-3
|
C14H26BNO2
|
|
AMOXICILLIN TRIHYDRATE IMP. D (EP) AS SODIUM SALT:(4S)-2-[[[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL]AMINO]-CARBOXYMETHYL]-5,5-DIMETHYLTHIAZOLIDINE-4-CARBOXYLIC ACID SODIUM SALT (PENICILLOICACIDS OF AMO
|
阿莫西林杂质D
|
1642629-94-4
|
C16H21N3O6S
|
|
(DES-PYR1)-LEUPROLIDE
|
(DES-PYR1,DES-GLY10,D-LEU6,PRO-NHET9)-LHRH
|
1642799-35-6
|
C54H79N15O10
|
|
6-broMo-5-(trifluoroMethyl)pyridin-3-aMine
|
6-溴-5-(三氟甲基)吡啶-3-胺
|
1642844-33-4
|
C6H4BrF3N2
|
|
Dabigatran iMpurity F
|
达比加群杂质F
|
1642853-67-5
|
C19H20N4O4
|
|
2-ALLYLOXY-BENZALDEHYDE OXIME
|
|
1642857-43-9
|
C10H11NO2
|
|
TLR7-IN-1
|
CS-2748
|
1642857-69-9
|
C17H16N6O2
|
|
N-Propylsulfuric diamide-sodium
|
丙胺基磺酰胺钠盐
|
1642873-03-7
|
C3H11N2NaO2S
|
|
Macitentan Impurity 11
|
马西替坦杂质11
|
1642873-04-8
|
C12H10BrClN2O2
|
|
tert-butyl 2-oxo-1-oxa-3,7-diazaspiro[4.4]nonane-7-carboxylate
|
叔-丁基 2-氧亚基-1-氧杂-3,7-二氮杂螺[4.4]壬烷-7-甲酸基酯
|
1642899-83-9
|
C11H18N2O4
|
|
SAfit2
|
1643125-33-0
|
1643125-33-0
|
C46H62N2O10
|
|
(R)-2-(1-(2-(bis(tert-butoxycarbonyl)amino)-5-bromopyridin-3-yloxy)ethyl)-4-fluorobenzoicacid
|
|
1643141-17-6
|
C24H28BrFN2O7
|
|
4-broMo-5-fluoro-2-hydrazinylbenzoic acid hydrochloride
|
4-BROMO-5-FLUORO-2-HYDRAZINYLBENZOIC ACID HYDROCHLORIDE
|
1643156-18-6
|
C7H7BrClFN2O2
|
|
(S)-5-bromo-6-fluoro-2-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide
|
1643156-23-3
|
1643156-23-3
|
C16H18BrFN2O2
|
|
5-Bromo-2-iodo-4-methyl-phenylamine
|
5-Bromo-2-iodo-4-methyl-phenylamine
|
1643156-27-7
|
C7H7BrIN
|
|
15406-A3
|
|
1643177-29-0
|
C11H12O
|
|
5-chloro-N-(4-(5-morpholino-6-oxo-3,6-dihydropyridin-1(2H)-yl)phenyl)pentanamide
|
5-氯-N-(4-(3-吗啉代-2-氧代-5,6-二氢吡啶-1(2H)-基)苯基)戊酰胺
|
1643330-62-4
|
C20H26ClN3O3
|
|
BMS-986142
|
BMS986142
|
1643368-58-4
|
C32H30F2N4O4
|
|
Dabigatran Etexilate iMpurity
|
达比加群酯杂质
|
1643377-48-3
|
C25H26N8O2
|
|
Ticagrelor Impurity N
|
替格瑞洛杂质N
|
1643378-47-5
|
C23H29FN6O4S
|
|
Ticagrelor Impurity 15
|
替格瑞洛杂质15
|
1643378-48-6
|
C23H28F2N6O4S
|
|
Dabigatran Etexilate iMpurity G
|
达比加群酯杂质G
|
1643392-59-9
|
C41H55N7O8
|
|
3-BROMO-N'-HYDROXYBENZENECARBOXIMIDAMIDE
|
(Z)-3-溴基-N'-羟基苯甲
|
1643440-91-8
|
C7H7BrN2O
|
|
(4-(4,6-diphenylpyridin-2-yl)phenyl)boronic acid
|
(4-(4,6-二苯基吡啶-2-基)苯基)硼酸
|
1643448-23-0
|
C23H18BNO2
|
|
2-(5-Chloro-2-(trifluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
2-(5-Chloro-2-(trifluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
1643467-83-7
|
C13H15BClF3O3
|
|
9-[1,1'-Biphenyl]-3-yl-9'-[1,1'-biphenyl]-4-yl-3,3'-bi-9H-carbazole
|
N-(3-联苯基)-N-(4-联苯基)-3,3-双咔唑
|
1643479-47-3
|
C48H32N2
|
|
1,3-di-tert-butyl-5-heptylbenzene
|
1,3-DI-TERT-BUTYL-5-HEPTYLBENZENE
|
1643540-34-4
|
C21H36
|
|
(R)-6-Fluoro-2-(piperidin-3-yl)isoindolin-1-one hydrochloride
|
|
1643571-00-9
|
C13H16ClFN2O
|
|
benzyl 5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine-1-carboxylate
|
噻嗪二酮
|
1643573-74-3
|
C19H26BNO4
|
|
tert-butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclopent-3-en-1-yl)carbamate
|
1643574-07-5
|
1643574-07-5
|
C16H28BNO4
|
|
Acid-PEG13-NHS ester
|
ACID-PEG13-NHS ESTER
|
1643594-31-3
|
(C2H4O)nC10H13NO7
|
|
9H-Fluoren-9-ol, 9-(4-dibenzofuranyl)-
|
9-(4-二苯并呋喃基)-9H-芴-9-醇
|
1643678-96-9
|
C25H16O2
|
|
Atomoxetine EP Impurity C HCl
|
托莫西汀EP杂质C盐酸盐
|
1643684-06-3
|
C17H21NO
|
|
4-(2-Benzoxazolyl)-N-phenylbenzenamine
|
3,3'-二羟基联苯胺
|
1643848-13-8
|
C19H14N2O
|
|
19-(tert-Butoxy)-19-oxononadecanoic acid
|
十九烷二酸单叔丁酯
|
1643852-37-2
|
C23H44O4
|
|
KPT-9294
|
KPT-9274
|
1643913-93-2
|
C35H29F3N4O3
|
|
4-((5-bromo-2-fluorophenyl)sulfonyl)morpholine
|
4-((5-溴-2-氟苯基)磺酰)吗啉
|
1643915-62-1
|
C10H11BrFNO3S
|
|
1-methyl-4-{1-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropyl}piperazine
|
1-methyl-4-{1-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropyl}piperazine
|
1643923-77-6
|
C20H31BN2O2
|
|
9,9-Dimethyl-10-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-9,10-dihydro-acridine
|
9,9-Dimethyl-10-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-9,10-dihydro-acridine
|
1643935-09-4
|
C27H30BNO2
|
|
Tos-PEG2-CH2CO2tBu
|
2-(2-(对甲苯磺酰氧基)乙氧基)乙酸叔丁酯
|
1643957-24-7
|
C15H22O6S
|
|
Benzyl-PEG3-CH2CO2tBu
|
苄基-PEG3-乙酸叔丁酯
|
1643957-26-9
|
C17H26O5
|
|
3-AMINO-4-PHENYLPYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
|
(3S,4R)-3-氨基-4-苯基吡咯烷-1-羧酸叔丁酯
|
1643979-48-9
|
C15H22N2O2
|
|
5-Methoxy-4-((4-Methoxybenzyl)oxy)-2-nitrobenzoic acid
|
5-甲氧基-4-((4-甲氧基苄基)氧基)-2-硝基苯甲酸
|
1643979-88-7
|
C16H15NO7
|
|
3-(9,9-dimethylacridin-10(9H )-yl)-9H -xanthen-9-one
|
3-(9- 9-二甲基嘧啶-10(9H)-基)-9H-黄嘌呤-9-酮
|
1643983-89-4
|
C28H21NO2
|
|
N-(9,9-dimethyl-9H-fluoren-4-yl)-9,9-dimethyl-9H-fluoren-2-amine
|
N-(9,9-二甲基-9H-芴-4-基)-9,9-二甲基-9H-芴-2-胺
|
1644054-07-8
|
C30H27N
|
|
N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine
|
N-(4-溴苯基)-9,9-二甲基-9H-芴-2-胺
|
1644059-09-5
|
C21H18BrN
|
|
Fumarate hydratase-IN-1
|
Fumarate hydratase 抑制剂1
|
1644060-37-6
|
C27H30N2O4
|
|
7-Methoxy-imidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester
|
7-甲氧基咪唑并[1,2-A]吡啶-3-甲酸乙酯
|
1644071-15-7
|
C11H12N2O3
|
|
1-(2-Propyn-1-yloxy)-4-(1,2,2-triphenylethenyl)benzene
|
[1-(4-丙炔氧基苯基)-1,2,2-三苯基]乙烯
|
1644078-88-5
|
C29H22O
|
|
benzyl 4-hydrazinylpiperidine-1-carboxylate dihydrochloride(WXC02324)
|
苯甲基 4-肼基哌啶-1-甲酸基酯二盐酸
|
1644088-97-0
|
C13H20ClN3O2
|
|
Acid Ceramidase Inhibitor 17a
|
ARN14974
|
1644158-57-5
|
C24H21FN2O3
|
|
Azido-PEG10-acid
|
叠氮-十聚乙二醇-羧酸
|
1644163-57-4
|
C23H45N3O12
|
|
PffBT4T-2OD
|
P1140
|
1644164-62-4
|
(C62H88F2N2S5)n
|
|
MPEG6-Mal
|
甲基-PEG6-琥珀酰亚胺
|
1644231-07-1
|
C20H34N2O9
|
|
ethyl 2-hydroxy-5,6,7,8-tetrahydro-1,6-naphthyridine-5-carboxylate hydrochloride
|
2-羟基-5,6,7,8-四氢-1,6-萘啶-5-羧酸乙酯 盐酸盐
|
1644236-95-2
|
C11H15ClN2O3
|
|
(12-oxo-5,6,11,12-tetrahydrobenzo[6,7]azepino[4,3-b]indole-4,10-diyl)bis((4-bromophenyl)methanone)
|
溴芬酸杂质3
|
1644279-16-2
|
C30H18Br2N2O3
|
|
6-Bromo-3,4-difluoro-2-nitrophenol
|
|
1644281-87-7
|
C6H2BrF2NO3
|
|
Pemetrexed disodium Ketone impurity
|
培美曲塞杂质7
|
1644287-27-3
|
C20H21N5O7
|
|
(1S,4R)-3-((((1R,2R)-2-((4-(1-oxidobenzo[d]isothiazol-3-yl) piperazin-1-yl)methyl)cyclohexyl)methyl)carbamoyl)bicycle [2.2.1]heptane-2-carboxylic acid
|
鲁拉西酮杂质24
|
1644295-07-7
|
C28H38N4O3S
|
|
MAVBUKOHERNHBQ-UHFFFAOYSA-N
|
鲁拉西酮杂质砜
|
1644295-09-9
|
C28H36N4O4S
|